Jennifer K. Moses

VP of Finance & Admin, G1 Therapeutics, Inc.

Companies

Viridian Therapeutics, Inc.\DEBoard member Jul 15, 2021 to now¹
G1 Therapeutics, Inc.Chief financial officer May 10, 2019 to Jan 5, 2023²
G1 Therapeutics, Inc.VP of Finance & Admin May 16, 2017 to Jan 17, 2019³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

G1 Therapeutics, Inc.57,820 shares⁴Jan 5, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 5, 2023Sold 729 shares at $5.41 of G1 Therapeutics, Inc.⁴
Jan 4, 2023Sold 1,639 shares at $5.58 of G1 Therapeutics, Inc.⁴
Jan 3, 2023Granted 22,300 shares of G1 Therapeutics, Inc.⁴
Feb 1, 2022Exercised options 2,000 shares at $4.17 of G1 Therapeutics, Inc.⁵
Feb 1, 2022Exercised options 333 shares at $3.72 of G1 Therapeutics, Inc.⁵
Jan 5, 2022Sold 1,445 shares at $10.61 of G1 Therapeutics, Inc.⁶
Jan 3, 2022Granted 12,000 shares of G1 Therapeutics, Inc.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARViridian Therapeutics, Inc.\DE, Board member
2
SEC EDGARG1 Therapeutics, Inc., Chief financial officer
3
SEC EDGARG1 Therapeutics, Inc., VP of Finance & Admin
4
SEC EDGARG1 Therapeutics, Inc. shares after the filing of Jan 5, 2023
5
SEC EDGARForm 4 filed Feb 2, 2022
6
SEC EDGARForm 4 filed Jan 5, 2022